25% Dextrose Infant 250 mg/mL
25% Dextrose Infant · INJECTION, SOLUTION · HF Acquisition Co. LLC, DBA Health First
25% Dextrose Infant is a injection, solution containing 25% dextrose infant at 250 mg/mL, taken intravenous. Manufactured by HF Acquisition Co. LLC, DBA Health First.
Key Facts
- Brand Name
- 25% Dextrose Infant
- Generic Name
- 25% Dextrose Infant
- NDC Code (Product)
51662-1213- Manufacturer
- HF Acquisition Co. LLC, DBA Health First
- Strength
- 250 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA019445
- Marketing Start
- 08/19/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is 25% Dextrose Infant used for?
25% Dextrose Infant contains 25% Dextrose Infant. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is 25% Dextrose Infant a controlled substance?
25% Dextrose Infant is not classified as a controlled substance by the DEA.
What is the generic name for 25% Dextrose Infant?
The generic name for 25% Dextrose Infant is 25% Dextrose Infant. There are no other listed brand versions of 25% Dextrose Infant.
What is the NDC code for 25% Dextrose Infant 250 mg/mL?
The NDC (National Drug Code) for 25% Dextrose Infant 250 mg/mL is 51662-1213, listed by HF Acquisition Co. LLC, DBA Health First.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)